Individual case reports Though rare, some patients have developed thyroid abnormalities while on GLP-1 drugs
In the LEADER trial (Marso, Daniels and colleagues), which studied the GLP-1 liraglutide, major cardiovascular events decreased by 13% in patients with type 2 diabetes at high cardiovascular risk
Work with your medical provider on a treatment plan that accounts for your weight loss journey over months and years, not weeks
If you are losing weight too fast, feeling weak, or struggling to train, do not keep cutting portions just because appetite is low
Scientific data point to non-exercise-related cramps being typically idiopathic (spontaneous and unattributable to a specific trigger), but their prevalence may relate to dietary factors as well